Eli Lilly (LLY) Interest & Investment Income (2009 - 2012)

Eli Lilly (LLY) has reported Interest & Investment Income for 4 consecutive years, with $26.1 million the latest figure, recorded in Q1 2012.

• Interest & Investment Income for Q1 2012 came in at $26.1 million, up 68.39% year-over-year; the trailing twelve-month figure through Mar 2012 was $90.5 million (up 59.33% YoY), and the FY2011 annual result was $79.9 million, up 53.95% from the prior year.
• Interest & Investment Income was $26.1 million for Q1 2012 at Eli Lilly, up from $24.4 million in the prior quarter.
• Over five years, Interest & Investment Income peaked at $718.7 million in Q3 2009 and troughed at $10.6 million in Q1 2010.
• Average Interest & Investment Income over 4 years is $81.4 million, with a median of $17.8 million recorded in 2011.
• Year-over-year, Interest & Investment Income tumbled 97.73% in 2010 and surged 74.29% in 2011.
• Over 4 years, Interest & Investment Income stood at $718.7 million in 2009, then plunged by 98.05% to $14.0 million in 2010, then soared by 74.29% to $24.4 million in 2011, then increased by 6.97% to $26.1 million in 2012.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $26.1 million in Q1 2012, $24.4 million in Q4 2011, and $22.2 million in Q3 2011.